However, in the case of MDS, only one study described USP7 expression in a cohort of 28 Asian patients, which showed upregulation of USP7 only in high-risk patients (SMD-EB-1 and MDS-EB-2). This evidence concerns the gene USP7 and myelodysplastic syndrome.